When a single pivotal trial should not be enough–the case of drotrecogin-alfa (activated)
Christian J. WiedermannVolume:
32
Langue:
english
Pages:
1
DOI:
10.1007/s00134-006-0086-9
Date:
April, 2006
Fichier:
PDF, 32 KB
english, 2006